IDBiologics: Funding, Investors & Team (Oct 2026)
IDBiologics was founded in 2017 to discover and develop human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.Their innovative fully human monoclonal antibody platform enables rapid discovery and optimization of broad and potent therapeutic molecules.Using this proprietary platform, IDBiologics has accumulated unparalleled breadth in isolating antibodies for infectious diseases, with lead candidate molecules to diverse targets moving forward in development.
IDBiologics has raised $500k across 2 funding rounds on record, the most recent a Seed of $500k announced in May 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
IDBiologics Company Profile and Key Stats
Latest funding round on record: May 2023.
IDBiologics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
IDBiologics announced a Seed in Dec 2022; the amount was not disclosed.
5 months later, a Seed of $500k was announced in May 2023.
IDBiologics Founders and Leadership Team
No contact details are on record for this team yet.
IDBiologics Funding Compared to Other Biotechnology Startups
IDBiologics' latest round of $500k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like IDBiologics in Biotechnology and Nashville
Companies Similar to IDBiologics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
IDBiologics Funding FAQs
What does IDBiologics do?
IDBiologics was founded in 2017 to discover and develop human monoclonal antibodies for the prevention, treatment, and cure of infectious diseases.Their innovative fully human monoclonal antibody platform enables rapid discovery and optimization of broad and potent therapeutic molecules.Using this proprietary platform, IDBiologics has accumulated unparalleled breadth in isolating antibodies for infectious diseases, with lead candidate molecules to diverse targets moving forward in development.
How much funding has IDBiologics raised?
IDBiologics has raised $500k across 2 rounds on record. The most recent is a Seed of $500k announced in May 2023.
When did IDBiologics last raise funding?
IDBiologics' most recent funding round on record is a Seed of $500k, announced in May 2023.
Who founded IDBiologics?
FundedIQ lists James Crowe (Founder) at IDBiologics.
Who is the CEO of IDBiologics?
Charles Haines is listed as CEO at IDBiologics.
Where is IDBiologics headquartered?
IDBiologics is based in Nashville, Tennessee, United States.
How many employees does IDBiologics have?
IDBiologics is in the 1-10 employee band.
How does IDBiologics' funding compare to other Biotechnology startups?
IDBiologics' latest round of $500k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's IDBiologics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for IDBiologics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.